Funding Announcements

"The founding team of EnsiliTech is not just a team of collaborators. There is deep respect between all members of the team… created as a result of aligned values, respect for each other’s personalities, diversity of thought and backgrounds…"

"There is a substantial unmet need today in neuroscience clinical studies. Many study endpoints are measured with traditional pen and paper assessments which lack objective data about brain function. Biopharma companies need objective data to effectively establish baseline information about whether a drug is engaging with the region of the brain that a particular drug is targeting, whether a drug is effective, and informing which cohort of patients may benefit the most from a particular drug."

"Research is highly complex and regularly takes unexpected turns but current software platforms often fail to allow this level of flexibility. As a result, researchers often resort to using paper or lose important data. Lab Thread aims to make their jobs easier by providing interfaces for both the office and lab, stripping out the paperwork and streamlining processes along the way."

"Portal Biotech’s technology offers unprecedented capabilities in protein identification and characterisation, providing unmatched detail on protein structure and modifications at the single-molecule level on accessible desktop instruments that bring this state-of-the-art characterisation to any lab. These powerful advances are essential for accelerating drug discovery and enhancing diagnostic precision, positioning Portal Biotech as the frontrunner in the race to unlock the full potential of protein sequencing."

"OutSee’s Nomaly technology is a truly next-generation genomic analysis tool with potential to transform drug discovery using powerful data-driven insights. It allows us to interrogate smaller datasets, and even data that has already been analysed, to uncover unique target insights that until now would have remained undetected."